Helicobacter Pylori Non-Invasive Testing Market

The global Helicobacter Pylori (H-Pylori) Non-Invasive Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances.
Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Helicobacter Pylori Non-Invasive Testing Market studies the Helicobacter Pylori (H-Pylori) Non-Invasive Testing market, Non-invasive diagnostic tests included stool antigen test, serological, and urea breath test, etc.
Helicobacter Pylori Non-Invasive Testing Market aims to provide a comprehensive presentation of the global market for Helicobacter Pylori (H-Pylori) Non-Invasive Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helicobacter Pylori (H-Pylori) Non-Invasive Testing. Helicobacter Pylori Non-Invasive Testing Market contains market size and forecasts of Helicobacter Pylori (H-Pylori) Non-Invasive Testing in global, including the following market information:

• Global Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global top five companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Urea Breath Test Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Helicobacter Pylori (H-Pylori) Non-Invasive Testing include Sekisui Diagnostics, Roche, Danaher, Abbott Laboratories, Medline Industries, Bio-Rad Laboratories, Thermo Fisher Scientific, Quidel and Cardinal Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Helicobacter Pylori (H-Pylori) Non-Invasive Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Segment Percentages, by Type, 2022 (%)
Urea Breath Test
Serology Test
Stool Antigen Test
Others
Global Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Segment Percentages, by Application, 2022 (%)
Hospitals
Physical Examination Center
Others
Global Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Helicobacter Pylori (H-Pylori) Non-Invasive Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Helicobacter Pylori (H-Pylori) Non-Invasive Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sekisui Diagnostics
Roche
Danaher
Abbott Laboratories
Medline Industries
Bio-Rad Laboratories
Thermo Fisher Scientific
Quidel
Cardinal Health
Agilent Technologies
Meridian Bioscience
Biomerica
DiaSorin S.p.A
Alpha Laboratories
EKF Diagnostics
Halyard Health, Inc
Coris BioConcept
Certest Biotec SL
Otsuka Pharmaceutical
Savyon Diagnostics
Kibion AB
Boditech Med Inc
Shenzhen Zhonghe Headway Bio-Sci & Tech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Helicobacter Pylori (H-Pylori) Non-Invasive Testing, market overview.
Chapter 2: Global Helicobacter Pylori (H-Pylori) Non-Invasive Testing market size in revenue.
Chapter 3: Detailed analysis of Helicobacter Pylori (H-Pylori) Non-Invasive Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Helicobacter Pylori (H-Pylori) Non-Invasive Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.